CLINICAL_TRIALS
withdrawal
· 2019-04-18
Clinical Trial Update: Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery [Phase 4]
Summary
A Phase 4 study investigating sphenopalatine ganglion block to prevent shoulder pain after laparoscopic bariatric surgery was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NYU Langone Health | Conditions: Obesity | Phase 4 | Status: WITHDRAWN